These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37660333)

  • 1. New Imaging Techniques.
    Chamadol N; Syms R; Laopaiboon V; Promsorn J; Eurboonyanun K
    Recent Results Cancer Res; 2023; 219():109-145. PubMed ID: 37660333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis.
    Huang X; Yang J; Li J; Xiong Y
    Medicine (Baltimore); 2020 Aug; 99(35):e20932. PubMed ID: 32871859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocarcinoma imaging: from diagnosis to response assessment.
    Cao J; Srinivas-Rao S; Mroueh N; Anand R; Kongboonvijit S; Sertic M; Shenoy-Bhangle AS; Kambadakone A
    Abdom Radiol (NY); 2024 May; 49(5):1699-1715. PubMed ID: 38578323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer activity using positron emission tomography-computed tomography and pharmacokinetics of β-eudesmol in human cholangiocarcinoma xenografted nude mouse model.
    Plengsuriyakarn T; Karbwang J; Na-Bangchang K
    Clin Exp Pharmacol Physiol; 2015 Mar; 42(3):293-304. PubMed ID: 25545782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis.
    Hu JH; Tang JH; Lin CH; Chu YY; Liu NJ
    J Investig Med; 2018 Jan; 66(1):52-61. PubMed ID: 28912249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiological diagnosis in cholangiocarcinoma: Application of computed tomography, magnetic resonance imaging, and positron emission tomography.
    Ringe KI; Wacker F
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):253-65. PubMed ID: 25966426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
    Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer Activity of Atractylodes lancea (Thunb.) DC in a Hamster Model and Application of PET-CT for Early Detection and Monitoring Progression of Cholangiocarcinoma.
    Plengsuriyakarn T; Matsuda N; Karbwang J; Viyanant V; Hirayama K; Na-Bangchang K
    Asian Pac J Cancer Prev; 2015; 16(15):6279-84. PubMed ID: 26434829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma.
    Gigante E; Ronot M; Bertin C; Ciolina M; Bouattour M; Dondero F; Cauchy F; Soubrane O; Vilgrain V; Paradis V
    Liver Int; 2019 Dec; 39(12):2386-2396. PubMed ID: 31544304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating a preoperative protocol that includes magnetic resonance imaging for lymph node metastasis in the Cholangiocarcinoma Screening and Care Program (CASCAP) in Thailand.
    Songthamwat M; Chamadol N; Khuntikeo N; Thinkhamrop J; Koonmee S; Chaichaya N; Bethony J; Thinkhamrop B
    World J Surg Oncol; 2017 Sep; 15(1):176. PubMed ID: 28931405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis.
    Annunziata S; Caldarella C; Pizzuto DA; Galiandro F; Sadeghi R; Giovanella L; Treglia G
    Biomed Res Int; 2014; 2014():247693. PubMed ID: 24955351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience.
    Mohamadnejad M; DeWitt JM; Sherman S; LeBlanc JK; Pitt HA; House MG; Jones KJ; Fogel EL; McHenry L; Watkins JL; Cote GA; Lehman GA; Al-Haddad MA
    Gastrointest Endosc; 2011 Jan; 73(1):71-8. PubMed ID: 21067747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating IgG4-related sclerosing cholangiopathy from cholangiocarcinoma using CT and MRI: experience from a tertiary referring center.
    Swensson J; Tirkes T; Tann M; Cui E; Sandrasegaran K
    Abdom Radiol (NY); 2019 Jun; 44(6):2111-2115. PubMed ID: 30783729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
    Sangfelt P; Sundin A; Wanders A; Rasmussen I; Karlson BM; Bergquist A; Rorsman F
    J Hepatol; 2014 Dec; 61(6):1352-7. PubMed ID: 25111173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
    Chi CT; Chau GY; Lee RC; Chen YY; Lei HJ; Hou MC; Chao Y; Huang YH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):125-133. PubMed ID: 30876788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification.
    Tawarungruang C; Khuntikeo N; Chamadol N; Laopaiboon V; Thuanman J; Thinkhamrop K; Kelly M; Thinkhamrop B
    BMC Cancer; 2021 May; 21(1):497. PubMed ID: 33941120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison Between Multidetector CT and High-Field 3T MR Imaging in Diagnostic and Tumour Extension Evaluation of Patients with Cholangiocarcinoma.
    D'Antuono F; De Luca S; Mainenti PP; Mollica C; Camera L; Galizia G; Brunetti A; Maurea S
    J Gastrointest Cancer; 2020 Jun; 51(2):534-544. PubMed ID: 31353420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.